Clinical Trials Sponsored by Ocellaris Pharma, Inc.
Total 2362 results
-
Astellas Pharma IncCompletedA Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisRenal Insufficiency | Chronic Kidney Disease | HyperphosphatemiaJapan
-
Astellas Pharma IncCompletedTransplantationFrance, Spain, Germany, United Kingdom, Ireland, Poland
-
Astellas Pharma IncCompletedLiver TransplantationFrance, Italy, Poland, Belgium, Spain, Germany, Switzerland, Canada, Finland, Brazil, Czech Republic, Australia, Norway, Sweden, United Kingdom, Ireland
-
Astellas Pharma IncCompletedKidney TransplantationAustralia, France, United Kingdom, Germany, Spain, Argentina, South Africa, Switzerland, Canada, Finland, Greece, Netherlands, Brazil, Belgium, Poland, Hungary, Czech Republic, Austria, Ireland, Italy, Mexico, Norway, Sweden
-
Antares Pharma Inc.CompletedUrinary Frequency | Urge Urinary IncontinenceUnited States
-
Astellas Pharma IncTerminatedKidney TransplantationUnited States
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncTerminatedBladder FunctionUnited States
-
SignPath Pharma, Inc.Completed
-
Antares Pharma Inc.Completed
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of ASP1941Japan
-
Astellas Pharma IncCompletedPsoriasisUnited States, Bulgaria, Latvia
-
Astellas Pharma IncTerminated
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics | CardiovascularUnited Kingdom
-
Astellas Pharma IncCompletedKidney TransplantationUnited States, Canada, Brazil
-
Astellas Pharma IncCompletedPost-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of TolterodineHealthy | Pharmacokinetics of Mirabegron and TolterodineJapan
-
Astellas Pharma IncTerminatedInvasive AspergillosisPoland, Belgium, Spain, France, Germany, Colombia, Brazil, Argentina, Hungary, Czech Republic, Croatia, Italy
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM178Japan
-
Astellas Pharma IncCompletedOveractive Bladder | PharmacokineticsFrance
-
Astellas Pharma IncCompletedAny Solid Tumor or LymphomaUnited States, Belgium, United Kingdom
-
Astellas Pharma IncCompletedLiver Transplantation | Hepatitis CItaly, France, Germany, Sweden, United Kingdom, Poland, Spain, Czech Republic
-
Astellas Pharma IncCompletedNon-Alcoholic SteatohepatitisUnited Kingdom, Belgium, Switzerland, Germany, France, Romania, Czech Republic
-
Astellas Pharma IncCompletedPharmacokinetics of AlefaceptUnited States
-
Astellas Pharma IncCompletedOveractive Bladder | Benign Prostatic Hyperplasia | Benign Prostatic HypertrophyJapan
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.CompletedType II Diabetes MellitusUnited States, Russian Federation, Czech Republic, Hungary, Netherlands
-
ZARS Pharma Inc.Completed
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedA Study to Investigate the Effect of Food on the Absorption, Distribution and Elimination of ASP1941Healthy | Pharmacokinetics of ASP1941Japan
-
ZARS Pharma Inc.Terminated
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.Completed
-
ZARS Pharma Inc.TerminatedPain | CancerUnited States
-
ZARS Pharma Inc.Completed
-
IASO Pharma Inc.TerminatedCommunity Acquired PneumoniaUnited States
-
Astellas Pharma IncTerminatedComparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICUInvasive Fungal InfectionsUnited States, Canada
-
ZARS Pharma Inc.CompletedHand DermatosesUnited States
-
Astellas Pharma IncCompletedThromboembolismSingapore, Indonesia, Japan, Korea, Republic of, Malaysia, Philippines, Taiwan, Thailand
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.Terminated
-
Astellas Pharma IncCompletedGastroesophageal RefluxJapan
-
Astellas Pharma IncCompletedCoronary Artery Disease | HypercholesteremiaJapan
-
Astellas Pharma IncCompletedHealthy Subjects | Drug Interactions | Pharmacokinetics of ASP015KUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic and Pharmacokinetic InteractionFrance
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of Solifenacin SuccinateUnited States
-
Astellas Pharma IncCompletedKidney TransplantationUnited States
-
Astellas Pharma IncCompletedHealthy | Plasma Concentration of YM060Japan